With the recent news of last week, these journals and studies, which included Vioxx won’t be available from Dr. Reuben.  Still no word yet from Johnson and Johnson so the merger appears to be moving along with Schering.  BD 

“A prominent Massachusetts anesthesiologist allegedly fabricated 21 medical studies that claimed to show benefits from painkillers like Vioxx and Celebrex, according to the hospital where he worked.

Baystate Medical Center, Springfield, Mass., said that its former chief of acute pain, Scott S. Reuben, had faked data used in the studies, which were published in several anesthesiology journals between 1996 and 2008.”

NEW YORK, March 23 (Reuters) - Merck & Co (MRK.N) said on Monday that it has been advised it is a target of a U.S. grand jury investigation involving its withdrawn pain drug Vioxx.

The company had previously disclosed the government probe, which has been ongoing since 2004. But it only last week received a letter from the U.S. Attorney's office for the District of Massachusetts informing the drugmaker it is a target of the grand jury investigation, Merck said.

The probe involves Merck's research, marketing and selling activities regarding Vioxx, the once $2.5 billion a year drug that was pulled from the market in September 2004 after a study showed it doubled the risk of heart attack and stroke in long-term users.

Merck target of Vioxx federal grand jury probe | Deals | Mergers & Acquisitions | Reuters

Related Reading:

Merck Purchases Insmed – Biosimilar Biotech Drug Company

Top Pain Scientist Fabricated Data in Pain Killer Studies – Was Money a powerful motivator

Johnson and Johnson and the Schering Plough Deal with Merck – Could Things change here?


Post a Comment

Google Analytics Alternative